Comparison of 24 h ECG Holter Monitoring with Real-time Long-term ECG Monitoring System using ECGalert Software and Savvy Single-Lead Patch by Poposka, Lidija et al.
12 https://www.id-press.eu/mjms/index
Scientific Foundation SPIROSKI, Skopje, Republic of Macedonia
Open Access Macedonian Journal of Medical Sciences. 2021 Jan 05; 9(B):12-17.
https://doi.org/10.3889/oamjms.2021.4960
eISSN: 1857-9655
Category: B - Clinical Sciences
Section: Cardiology
Comparison of 24 h ECG Holter Monitoring with Real-time 
Long-term ECG Monitoring System using ECGalert Software and 
Savvy Single-Lead Patch
Lidija Poposka1,2*, Marija Vavlukis1,2, Hristo Pejkov1,2, Marjan Gusev3
1University Clinic for Cardiology, Skopje, Republic of Macedonia; 2Faculty of Medicine, Ss.Ciril and Methodius University, 
Skopje, Republic of Macedonia; 3Faculty of Computer Science and Engineering, Ss.Ciril and Methodius University, Skopje, 
Republic of Macedonia
Abstract
AIM: The aim of the study was to show non-inferiority of the single-channel ECGalert system to the gold standard 
(ECG Holter) in the detection of arrhythmias over the total wear time of both devices.
METHODS: A prospective study enrolled a total of 165 patients hospitalized at the University Clinic of Cardiology, 
who underwent simultaneous single-channel ECG recording with ECGAlert system and a conventional 24 h Holter 
monitor on the 1st day and continued ECGAlert monitoring for few more days, under assignment of the doctor or at 
the wish of the patient.
RESULTS: A total of 165 patients were included in the study, 61.2% male, mean age of 58.4 ± 12.7 years. Mean 
duration of ECG Holter monitoring was 23.2 ± 0.5 h and mean duration of ECGalert/Savvy monitoring was 64.6 ± 31.2. 
During the first 24 h of simultaneous ECG monitoring with both methods, no statistically significant difference was 
found in arrhythmia detection. Over the total wear time of both devices, the ECGalert system detected significantly 
more AF episodes as compared to Holter (p < 0.000). ECGalert demonstrated significantly lower detection rate of 
false pauses (0.001). However, false detection of episodes of VT or AF was significantly higher in ECGalert system 
versus Holter (p < 0.000 and p < 0.000 respectively). Patients were more satisfied with ECGalert system, due to 
lesser interference in daily activities.
CONCLUSION: The ECGalert system demonstrated superiority over traditional Holter monitoring in arrhythmia 
detection in the total monitoring period, but not in the first 24 h.
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Introduction
Rhythm disturbances are often transient and in 
some patients go easily undiagnosed with conventional 
methods. Even further, some of the arrhythmias may 
be asymptomatic, which could lead to undertreatment, 
like inefficient stroke prevention in asymptomatic atrial 
fibrillation (AF). Opportunistic screening for AF has 
Class I recommendation, level of evidence B (by pulse 
taking or ECG rhythm strip) in patients >65 years of 
age, according to European Society of Cardiology 
(ESC) Guidelines for the management of AF [1]. In 
stroke patients, additional ECG monitoring by long-
term noninvasive ECG monitors or implanted loop 
recorders should be considered to document silent 
atrial fibrillation (Class IIa recommendation, level of 
evidence B). [1].
Furthermore, the diagnosis of syncope, pre-
syncope, or palpitations due to sustained arrhythmia 
remains a difficult task in clinical cardiology, often 
leading to multiple admittances to the emergency 
cardiology or neurology room and repetition of different 
diagnostic tests.
The most frequent used three-channel Holter 
ECG has at least five wires, it is bulky and many 
patients find it uncomfortable to wear, especially if they 
should wear it for up to 72 h. Different patient operated 
devices [2], [3] and prolonged continuous ECG 
monitoring with skin patches [4] have been tested and 
validated for detection of different rhythm disturbances 
in different patient cohorts.
Experience with single-channel ECG 
monitoring patches is limited, as it is a new concept. 
It is definitely more comfortable for the patient, but the 
diagnostic ability should be tested.
The aim of the study was to show non-
inferiority of the single-channel ECG monitoring to 
the gold standard (Holter monitoring) in the detection 
of arrhythmia events over the total wear time of both 
devices.
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Methods
A prospective study enrolled a total of 
165 patients hospitalized at the University Clinic of 
Cardiology, in Skopje, with different cardiac problems. 
The Institutional Ethic Board approved the protocol and 
all patients signed informed consent before the ECG 
monitoring. Inclusion criteria were hospitalization at the 
clinic of cardiology, the capability to understand, and 
signed informed consent. Patients were allowed to 
discontinue the ECG monitoring at any time if they fill 
uncomfortable by any means. Excluded patients from 
the study were those hospitalized in the intensive care 
unit, critically ill patients, and patients with implanted 
devices – pacemakers, or defibrillators.
Savvy device and ECGalert system
Savvy is a small personal device with an ECG 
sensor for long-term ECG monitoring. It is a certified 
product (CE, medical device), already on market. It 
communicates through wireless connection (Bluetooth 
Low Energy) to a smartphone. The device is small, 
water resistant, it could be easily detached, and self-
applied again by the patient. It is comfortable and does 
not interfere with the everyday activities of the patient. 
The device communicates with a smartphone through 
Bluetooth connection and the data are transferred 
from the smartphone to the internet-based web portal 
ECGalert (Figure 1). Monitoring is in continuity as 
long as the patient wants, or as long as, the doctor 
has established the diagnoses. During the monitoring 
period, the patient could have a real-time view of the 
ECG signal and also could use the “mark event” option 
to select the symptomatic moment for later correlation 
with an ECG finding. 
Study protocol
All patients underwent simultaneous single-
channel ECG recording with ECGAlert system during 
24 h and a conventional 24 -h Holter monitor on the 
same day, under the same condition. The devices were 
activated consecutively. The Holter monitoring was 
discontinued after 24 h and Savvy device was detached 
at a different time under assignment of the doctor 
(established diagnosis) or at the wish of the patient.
The patients were furthermore questioned about 
any discomfort and their general satisfaction with wearing 
both of the systems. Their answers were classified as 
“Holter better,” “Savvy better,” or “same.” The satisfaction of 
the doctors with quality of ECG analysis, time-consuming, 
diagnostic help was also questioned and answers classified 
as “Holter better,” “Savvy better,” or “same.”
The ECG analysis was done semi-automatically, 
as it is usual practice in the Holter laboratory. The doctor 
checks significant strips pre-selected by the computer 
analysis and defines them as correct or false positive. 
Afterward, the doctor goes through the full disclosure 
ECG recording looking for false-negative results.
The important rhythm disturbances were 
pre-selected and defined as pause longer than 
3 s, premature supraventricular/atrial beats (PAC), 
premature ventricular beats (PVC), supraventricular 
tachycardia (SVT), ventricular tachycardia (VT), and 
atrial fibrillation (AF).
The ability to pick up arrhythmia events by 
both devices was compared during the period of 
Figure 1: Chart showing data acquisition, transfer, analysis, and reporting in ECGalert system
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24 h. Afterward, the diagnostic yield of prolonged 
monitoring was analyzed. McNemar’s tests were used 
to compare the matched pairs of data from the Holter 
ECG monitoring and ECG alert monitoring system. 
Descriptive statistics were used for age, total wear time, 
and survey results.
Results
A total of 165 were included in the study, 61.2% 
of male, with a mean age of 58.4 ± 12.7 years. Mean 
duration of ECG Holter monitoring was 23.2 ± 0.5 h and 
mean duration of ECGalert/Savvy monitoring was 64.6 ± 
31.2 h (range from 23 h up to 246 h). The first 24 hours 
during simultaneous recording were used for comparison 
of both systems in terms of non-inferiority. As a next step, 
a comparison was made between 24 h Holter and total 
monitoring time with the ECGalert/Savvy system.
Device performance over simultaneous 
initial 24 h monitoring period
No statistically significant difference was found 
between two ECG monitoring methods during the first 
24 h. There were no pauses longer than 3 s, no AV 
blocks, and diagnostic yield of other rhythm disturbances 
was almost the same (Table 1). There were only a few 
cases where PAC or PVC was diagnosed differently by 
devices.
Table  1: Ability  to  diagnose  predefined  rhythm  disturbances 
during the first 24 h of monitoring
Test statisticsa Holter PAC 
and Savvy 
PAC
Holter SVT 
and Savvy 
SVT
Holter AF 
and Savvy 
AF
Holter PVC 
and Savvy 
PVC
Holter VT and 
Savvy VT
N 165 165 165 165 165
Exact sig. 
(two tailed)
1.000b 1.000b 1.000b 1.000b 1.000b
a.  McNemar’s 
test
b.  Binomial 
distribution 
used.
Device performance over total wear time
Longer ECG monitoring period made a 
difference in the diagnostic yield of the device. Three 
new episodes of AV block were detected with ECGalert/
Savvy system after 24 h, 6 episodes of non-sustained 
VT, and 9 new episodes of PVC, but the difference was 
no statistically significant (Table 2).
Statistically, a significant difference was 
reached in AF detection (Tables 2 and 3). As we 
expected, a longer monitoring period meant more 
diagnosed episodes. During prolonged monitoring, 25 
new episodes of AF were detected in patients previously 
not diagnosed as AF.
In our patient, Group AF episodes appeared 
in 35 patients (21.2%). Mean time for detection 
of AF was 34.4 ± 27.8 h. In the first 24 h, only 10 
cases of AF were diagnosed (28.6%), which means 
that if the ECG monitoring was stopped after 24 h, 
71.4% of the AF diagnoses would have been missed 
(Figure 2).
Table  3: Atrial  fibrillation  detection  in  24  h  by Holter  ECG  in 
comparison with monitoring time after 24 h with ECGalert/
Savvy system
Holter AF/Savvy ECGalert AF total monitoring time No Yes
Yes 140 15
No 0 10
False detections of pauses, VT, or AF episodes 
were different between the devices and this difference 
was statistically significant (p < 0.01). False detection 
of pauses was more frequent with Holter ECG (33 vs. 
10 cases), but false detection of VT and AF was more 
frequent with ECGalert/Savvy system (44 vs. 3 and 18 
vs. 2, respectively) (Table 4).
Figure 2: Time to detection of AF with ECGalert/Savvy device in 
hours
According to patients, ECGalert/Savvy system 
was better to use (58.8%) or equal to Holter (41.2%). 
Mean period of monitoring at patients that were more 
satisfied with ECGalert/Savvy system was 73.7 ± 36.1 h 
versus 51.6 ±15.2 h in patients that feel the same for 
both monitoring systems.
Table  2:  Ability  to  diagnose  predefined  rhythm  disturbances 
during the total time of monitoring (24 h for Holter ECG and 
ECGalert/Savvy system)
Test statisticsa Holter 
Pauses and 
ECGalert 
Savvy 
pauses
Holter 
PAC and 
ECGalert 
Savvy 
PAC
Holter 
SVT and 
ECGalert 
Savvy 
SVT
Holter 
AF and 
ECGalert 
Savvy AF
Holter 
PVC and 
ECGalert 
Savvy 
PVC
Holter 
VT and 
ECGalert 
Savvy 
VT
Holter AV 
block and 
ECGalert 
Savvy AV 
block
N 165 165 165 165 165 165 165
Exact sig. 
(two tailed)
1.000b 1.000b 0.625b 0.000b 0.064b 0.125b 0.250b
a.  McNemar’s 
test
b.  Binomial 
distribution 
used.
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Regarding the preference of doctors, both 
systems were equal. Mean time for data analysis for 
Holter ECG was 20.1 ± 2.8 min (23.2 h monitoring mean 
value) and 27.5 ± 10.1 for ECGalert system (64.6  h 
monitoring mean value).
Discussion
The primary goal of long-term ECG monitoring 
is to establish a diagnosis in patients complaining 
of palpitations, syncope, or to detect asymptomatic 
(silent) arrhythmias. Despite the clear usefulness of 
ECG olHiolterHolter monitoring (24–72 h), patients 
finding it robust and limiting their every day activities. 
Single-channel Savvy device is incomparably more 
comfortable to wear, water-resistant, ECGalert 
monitoring is time unlimited, can be easily detached 
by the patient, and attached again. Nowadays, there is 
an increasing interest in telemedicine. With ECGalert 
system, patient sends data continuously to the web 
platform which the doctor can easily access.
Many single-channel ECG devices have 
appeared on the market in the last decade, to replace 
conventional 24 h Holter monitor. The Zio Patch, FDA-
cleared, adhesive patch for a continuous 24 h monitoring 
over 2 weeks detected significantly more arrhythmia 
events than the Holter monitor [4]. The very important 
difference between Zio Patch and ECGalert system is 
that at the end of the 2 weeks, the patch must be sent 
back to the platform for a full analysis and a diagnostic 
report is then relayed to the patient’s physician, and 
ECGalert system sends data continuously to the web 
platform that can be assessed any time. Monitoring with 
ECGalert may be prolonged unlimited time.
Regarding patients preference, 93.7% 
of patients had found the adhesive patch monitor 
comfortable to wear and 81% indicating that they 
would prefer it over the Holter monitor [4]. Furthermore, 
physicians thought that a definitive diagnosis was 
achieved more often using the adhesive patch monitor 
as opposed to the Holter monitor [4]. During this study, 
we conducted a simple survey of patients and doctors 
regarding both ECG monitoring systems. Our survey 
of patient satisfaction with the device was similar, but 
not so strong in favor of Savvy device versus Holter, 
probably because the research was conducted in 
a hospital setting. For the same reason in our study, 
doctors have found both systems equal. However, 
in our previous work with ECGalert system, all of 
the surveyed participants answered that they would 
recommend ECGalert/Savvy and find it comfortable 
and easy to use [5].
The question if home-based self-applied 
wearable ECG patch can improve the diagnoses of 
AF was addressed and answered by the mSToPS 
Randomized Clinical Trial [6]. In this large trial (2659 
participants), immediate monitoring using a self-applied 
ECG patch led to a significantly higher rate of AF 
diagnosis at 4 months (3.9% vs. 0.9%) in comparison 
with delayed ECG monitoring for 4 months [5]. In our 
study, monitoring was prolonged maximum to 246 h 
(mean monitoring time 64.6 ± 31.2 h) and that has led 
to the diagnosis of AF in 25 more patients (71.4% of 
all AF patients). Meantime for the detection of AF was 
34.4 ± 27.8 h. Although Zio Patch has 14-day approved 
wear time, the highest diagnostic yield for arrhythmia 
detection was usually the first 7 days of ambulatory ECG 
monitoring [4], [7]. Using ECGalert system monitoring 
could be prolonged to the time, the diagnoses have 
been established and then discontinued. There is no 
need to unnecessarily prolongation of monitoring time.
For silent AF detection innovative iPhone ECG 
technology has been engaged [8]. SEARCH-AF, a cross-
sectional study was aimed to determine the feasibility, 
impact, and cost-effectiveness of community pharmacy-
based screening, using innovative iPhone ECG 
technology to identify previously undiagnosed AF [9]. 
An automated AF algorithm provided high accuracy 
for diagnoses of AF when used in a community setting 
and is a feasible and cost-effective strategy that could 
potentially reduce the high cost and societal burden 
of stroke and systemic thromboembolism associated 
with AF [8], [9]. Automated algorithm in ECGalert also 
has high accuracy for diagnoses of AF, VT, and other 
predefined rhythm disturbances (Figure 3). 
We want to emphasize that the information 
provided by the ECG Holter monitors (three or 12 
channel) is an obvious advantage for the analysis 
of electrical axes, aberrant QRS complexes, and 
ST-segment changes. However, evidence from our 
and some other studies indicate that no episode of 
SVT or AF detected by three-channel Holter ECG was 
undetected by the ECGalert system [4], [10].
Advantage of ECGalert system over different 
external loop-recording techniques [11], [12] is the 
Table 4: False detection of pauses, episodes of VT, and episodes of AF
Test statisticsa Holter false detection of pauses and 
ECGalert/Savvy false detection of pauses
Holter false detection of VT and ECGalert/
Savvy false detection of VT
Holter false detection of AF and ECGalert/
Savvy false detection of AF
N 165 165 165
Chi-Squareb 11.256 34.043
Asymp. sig. 0.001 0.000
Exact sig. (two tailed) 0.000c
a. McNemar’s test
b. Continuity corrected
c. Binomial distribution used
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availability of full-disclosure ECG record for analysis, 
not only predefined diagnosis strips or patient selected 
events.
Study limitations
The patients enrolled in this study were 
hospitalized patients with previously diagnosed 
heart diseases. This was not an ambulatory ECG 
monitoring by definition, while participants were in the 
ward hospital conditions, not much physically active. 
Although the majority had no previously documented 
arrhythmia, several had pre-existing arrhythmias and 
were referred for reasons other than symptomatic 
arrhythmia. In future practice, ECGalert system should 
be used as ambulatory ECG monitoring for a longer 
time period.
Conclusion
During the first 24 h of simultaneous ECG 
monitoring with both methods, no statistically 
significant difference was found in arrhythmia 
detection. Over the total wear time of both devices, 
the ECGalert system detected significantly more AF 
episodes than the Holter monitor. The difference was 
found in detection of AV blocks and NSVTs, but not 
statistically significant.
On the basis of these findings, single-channel, 
prolonged duration, ECG monitoring with ECGalert 
system may soon replace conventional Holter monitoring 
platforms for the detection of arrhythmia events in 
patients referred for ambulatory ECG monitoring.
In the future, this monitoring platform with 
very comfortable devices may develop new diagnostic 
algorithms for heart rate variability analysis, interplay 
with other chronic disease, and correlation with exercise 
or drug regiments.
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